Nacol Biotech announced that it has raised tens of millions in a round of funding on August 11, 2023. The transaction included participation from new investors, SYoung Group Co., Ltd., Shike Venture Capital, Nanjing Chuangyi Longmen Furuida Venture Capital Partnership Enterprise (L.P.), a fund managed by Zhuhai Longmen Capital Management Co., Ltd., an investment arm and individual investors.